The typical MRM transition monitored for tirzepatide is m/z 1204.4 (precursor, [M+5H]5+) to m/z 1473.6 (product) , with semaglutide often used as an internal standard (m/z 1029.4 to m/z 1238.4)
This consistency is important for maintaining steady progress and avoiding fluctuations in treatment outcomes
Dieguez M, Herrero A, Avello N, Suarez P, Delgado E, Menendez E
A ring can tell you what it is costing your sleep, your recovery, your heart rate, and your muscle
However, severe tiredness combined with other concerning symptoms (severe nausea, dizziness, chest pain) warrants immediate medical attention